HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mina Tsukamoto Selected Research

YM348

7/2013Systemic administration of 5-HT(2C) receptor agonists attenuates muscular hyperalgesia in reserpine-induced myalgia model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mina Tsukamoto Research Topics

Disease

6Hyperalgesia
10/2018 - 05/2010
4Pain (Aches)
10/2018 - 12/2013
3Neuralgia (Stump Neuralgia)
10/2018 - 01/2011
2Myalgia
10/2018 - 07/2013
2Fibromyalgia (Fibrositis)
10/2018 - 07/2013
1Seizures (Absence Seizure)
01/2021
1Glycosylphosphatidylinositol deficiency
01/2021
1Drug Resistant Epilepsy
01/2021
1Arthritis (Polyarthritis)
10/2018
1Hypersensitivity (Allergy)
06/2014
1Cerebrovascular Disorders (Cerebrovascular Occlusion)
03/2014
1Obesity
07/2013
1Schizophrenia (Dementia Praecox)
07/2013
1Chronic Pain
07/2013
1Central Nervous System Diseases (CNS Diseases)
07/2013
1Acute Pain
01/2011
1Alzheimer Disease (Alzheimer's Disease)
11/2004

Drug/Important Bio-Agent (IBA)

5Analgesics (Analgesic Drugs)IBA
10/2018 - 05/2010
3Duloxetine Hydrochloride (Cymbalta)FDA Link
06/2014 - 05/2010
2Reserpine (Serpasil)FDA Link
10/2018 - 07/2013
2Norepinephrine (Noradrenaline)FDA LinkGeneric
06/2014 - 03/2014
2Antidepressive Agents (Antidepressants)IBA
06/2014 - 03/2014
2Serotonin (5 Hydroxytryptamine)IBA
06/2014 - 03/2014
2indeloxazineIBA
06/2014 - 03/2014
2Amitriptyline (Elavil)FDA LinkGeneric
06/2014 - 03/2014
2Dinoprostone (PGE2)FDA Link
06/2014 - 05/2010
2LigandsIBA
01/2011 - 05/2010
1Immunoglobulin D (IgD)IBA
01/2021
1Kainic Acid (Kainate)IBA
01/2021
1ASP3662IBA
10/2018
1EnzymesIBA
10/2018
1GlucocorticoidsIBA
10/2018
1Hormones (Hormone)IBA
10/2018
1Oxidoreductases (Dehydrogenase)IBA
10/2018
1Streptozocin (Streptozotocin)FDA Link
10/2018
15-HT1A Serotonin ReceptorIBA
06/2014
1ProstaglandinsIBA
06/2014
15-HT3 Serotonin Receptors (5 HT3 Receptor)IBA
06/2014
1resiniferatoxinIBA
06/2014
1morpholineIBA
03/2014
1VeratridineIBA
12/2013
1Sodium Channels (Sodium Channel)IBA
12/2013
15-HT2C Serotonin ReceptorIBA
07/2013
1vabicaserinIBA
07/2013
1YM348IBA
07/2013
1lorcaserinIBA
07/2013
1TRPV1 receptorIBA
01/2011
1N- (1- methyl- 2- oxo- 1,2,3,4- tetrahydro- 7- quinolyl)- 2- ((2- methylpyrrolidin- 1- yl)methyl)biphenyl- 4- carboxamideIBA
01/2011
1Protons (Proton)IBA
01/2011
1Capsaicin (Zostrix)FDA Link
01/2011
1Dihydrotachysterol (AT 10)IBA
01/2011
1BicucullineIBA
05/2010
1Calcium Channels (Calcium Channel)IBA
05/2010
1Mexiletine (Mexitil)FDA LinkGeneric
05/2010
1Serotonin and Noradrenaline Reuptake InhibitorsIBA
05/2010
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
05/2010
1N-Methylaspartate (NMDA)IBA
05/2010
1Glutamic Acid (Glutamate)FDA Link
05/2010
1N-Type Calcium Channels (N-Type Calcium Channel)IBA
05/2010
1Sodium Channel BlockersIBA
05/2010
1Pregabalin (Lyrica)FDA Link
05/2010
1gamma-Aminobutyric Acid (GABA)IBA
05/2010
1ziconotide (Prialt)FDA Link
05/2010
1GABA-A Receptors (GABA(A) Receptor)IBA
05/2010
1Amyloid (Amyloid Fibrils)IBA
11/2004

Therapy/Procedure

2Ligation
10/2018 - 01/2011
1Oral Administration
10/2018
1Analgesia
06/2014
1Spinal Injections
06/2014
1Therapeutics
07/2013